Authors
Latest:
A Novel Amorphous Delivery System to the Skin for Poorly Soluble ActivesDrugs in the amorphous form are loaded into porous silica particles, which provide a maintained concentration gradient for skin delivery.
Latest:
A Novel Amorphous Delivery System to the Skin for Poorly Soluble ActivesDrugs in the amorphous form are loaded into porous silica particles, which provide a maintained concentration gradient for skin delivery.
Latest:
A Perspective on Computer ValidationThis article provides a historical review of computer validation in the pharmaceutical industry within the last three decades, evolving from the early years' initial concept and approach to today's current practices. Also included is how the regulations and industry have progressed in addressing the topic of computer validation.
Latest:
Liposomes, Part II: Drug delivery systemsNon-toxic and biodegradeable, biologically active liposomes encapsulate therapeutics to provide an attractive drug delivery system for the future.
Latest:
Liposomes, Part II: Drug delivery systemsNon-toxic and biodegradeable, biologically active liposomes encapsulate therapeutics to provide an attractive drug delivery system for the future.
Latest:
Liposomes, Part II: Drug delivery systemsNon-toxic and biodegradeable, biologically active liposomes encapsulate therapeutics to provide an attractive drug delivery system for the future.
Latest:
Partnership Models Structure R&D ChangePharmaceutical companies are adopting multiple choice partnership strategies to meet the challenges of today's R&D instead of being focused primarily on internal development.
Latest:
Identifying and Solving Scale-up Challenges in the Synthesis and Formulation of Small-Molecule APIsJoin expert Peter Poechlauer to understand the essentials of API process development to ensure a smooth pathway for scale up. Live: Thursday, Sept. 12, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Sept. 12, 2020 Register free
Latest:
Maintaining GxP with a 21 CFR Part 11-Compliant Tracking SystemIncorporating the right quality-management tool can facilitate Part 11 compliance.
Latest:
Maintaining GxP with a 21 CFR Part 11-Compliant Tracking SystemIncorporating the right quality-management tool can facilitate Part 11 compliance.
Latest:
Establishing Compliance of Batch SCADA Systems with FDA CGMP 21 CFR Part 11Batch SCADA systems are assessed for regulatory compliance and functionality.
Latest:
Toward Twenty-First-Century Sales and Operations PlanningBusiness models, processes, and planning technology must be current to allow companies to replan quickly and remain competitive.
Latest:
Tablet Relaxation and Physiocomechanical Stability of Lactose, Microcrystalline Cellulose, and Dibasic Calcuim PhosphateThe authors discuss the physiocomechanical characteristics of three commonly used pharmaceutical excipients and describe the effects of variables on their physiocomechanical stability.
Latest:
Toward Twenty-First-Century Sales and Operations PlanningBusiness models, processes, and planning technology must be current to allow companies to replan quickly and remain competitive.
Latest:
Tablet Relaxation and Physiocomechanical Stability of Lactose, Microcrystalline Cellulose, and Dibasic Calcuim PhosphateThe authors discuss the physiocomechanical characteristics of three commonly used pharmaceutical excipients and describe the effects of variables on their physiocomechanical stability.
Latest:
Tablet Relaxation and Physiocomechanical Stability of Lactose, Microcrystalline Cellulose, and Dibasic Calcuim PhosphateThe authors discuss the physiocomechanical characteristics of three commonly used pharmaceutical excipients and describe the effects of variables on their physiocomechanical stability.
Latest:
Tablet Relaxation and Physiocomechanical Stability of Lactose, Microcrystalline Cellulose, and Dibasic Calcuim PhosphateThe authors discuss the physiocomechanical characteristics of three commonly used pharmaceutical excipients and describe the effects of variables on their physiocomechanical stability.
Latest:
Truth in OutsourcingContract service providers and clients alike must be realistic and forthcoming about their expectations to accomplish a truthful outsourcing partnership.
Latest:
A Comprehensive Approach to Pharmaceutical Engineering TrainingA training program at Rutgers University combines the disciplines of engineering and pharmaceutics to provide a thorough educational experience in drug manufacturing.
Latest:
Investigation of Out-of-Specification ResultsThe authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.
Latest:
Investigation of Out-of-Specification ResultsThe authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.
Latest:
Investigation of Out-of-Specification ResultsThe authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.
Latest:
Novel Acrylate Adhesives for Transdermal Drug DeliveryThe authors discuss the solubility and adhesive performances of adhesives that incorporate monomers such as hydroxyethyl acrylate or pyrrolidonoethyl acrylate.
Latest:
Reaping the Benefits of E-ProcurementImplementing an e-procurement solution requires executive sponsorship, up-front analysis of current processes, integration with back-end systems, and change mangement.
Latest:
The Role of Computational Fluid Dynamics in the Pharmaceutical IndustryComputational fluid dynamics can be a valuable tool for analyzing the efficiencies and performances of process equipment, which can lead to potential cost savings.
Latest:
The Role of Computational Fluid Dynamics in the Pharmaceutical IndustryComputational fluid dynamics can be a valuable tool for analyzing the efficiencies and performances of process equipment, which can lead to potential cost savings.
Latest:
Available Guidance and Best Practices for Conducting Forced Degradation StudiesParticipants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Latest:
Available Guidance and Best Practices for Conducting Forced Degradation StudiesParticipants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
